![CAS No 143824-78-6 ((2S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-[1-[ (2-METHYLPROPAN-2-YL)Oxycarbonyl]Indol-3-Yl]Propanoic Acid Pharmaceutical Intermediates](https://ecdn6.globalso.com/upload/p/2209/image_other/2025-11/143824-78-6-structural-formula_thumbW360.jpg)
Nilotinib base CAS No.641571-10-0 Pharmaceutical Intermediates
Introduction
Nilotinib base is a highly potent tyrosine kinase inhibitor that plays a vital role in the treatment of chronic myeloid leukemia (CML). It specifically targets the BCR-ABL fusion protein, which is responsible for the proliferation of cancer cells in CML. By inhibiting this protein, Nilotinib base helps control the growth of cancer cells and improves patient outcomes.
As a manufacturer and trader, we take pride in producing high-quality Nilotinib base to meet the specific needs of our customers in the pharmaceutical industry.
Physical and Chemical Properties
- Appearance: White powder, stable under standard storage conditions.
- Melting point: about 150-155°C, indicating good thermal stability.
- Solubility: Nilotinib base is soluble in organic solvents and has moderate solubility in water, enhancing its applicability in various pharmaceutical formulations.
- pH: Slightly alkaline, which can be beneficial in some formulations.
These properties not only enhance the reactivity of the compound but also ensure its compatibility with a wide range of other chemicals used in drug formulations.
1. Targeted Cancer Therapy: Nilotinib is specifically designed to treat chronic myeloid leukemia, providing a targeted treatment for this serious disease.
2. Improved stability and solubility: The base form of nilotinib enhances the stability and solubility of the compound, thereby achieving more effective dosing and better therapeutic effects.
3. High Purity and Quality: Our stringent quality control process ensures that Nilotinib Base is of high purity, minimizing impurities that may affect the efficacy of the final drug product.
4. Stable and reliable performance: The chemical stability of Nilotinib base ensures that it maintains its properties over time, providing consistent results in a variety of applications.
5. Regulatory Compliance: Our manufacturing processes comply with Good Manufacturing Practices (GMP) and other international regulations, ensuring our products meet the highest safety and quality standards.
Nilotinib base is mainly used in the pharmaceutical industry for various purposes:
- Chronic Myeloid Leukemia Treatment: Nilotinib is widely used to treat chronic myeloid leukemia, especially in patients who are resistant or intolerant to other therapies. It is effective in reducing the number of cancer cells and improving overall survival.
- Research and Development: Ongoing research continues to explore the potential of nilotinib in new therapeutic areas, underscoring its importance in the pharmaceutical field.
- Combination Therapy: Nilotinib can be used in combination with other cancer therapies to enhance the effectiveness of treatment and improve patient outcomes.
As a leading manufacturer and trader of Nilotinib Base, we are committed to providing high-quality products that meet the evolving needs of the pharmaceutical industry. Our commitment to excellence, coupled with our integrated approach to production and trading, makes us a trusted partner for pharmaceutical companies around the world. By choosing our Nilotinib Base, you can ensure that your formulations meet the highest standards of quality and efficacy, ultimately helping to improve patient outcomes.
To learn more about our products and services, please contact us today. We look forward to working with you to advance healthcare solutions.